M. Bertran

发表

Analysis of the quality of patient therapeutic education and information in a high complexity reference hospital.

J. Escarrabill, J. Vilardell, M. Jansà, 2018, Journal of healthcare quality research.

Immunogenicity and reactogenicity of the adult tetanus–diphtheria vaccine. How many doses are necessary?

J. Bayas, J. Vidal, L. Salleras, 2001, Epidemiology and Infection.

[Validation of the EuroSCORE probabilistic model in patients undergoing coronary bypass grafting].

J. Pomar, Sarah Lafuente, A. Trilla, 2008, Revista espanola de cardiologia.

Prevalence of hepatitis B infection in long-stay mentally handicapped adults

J. Bayas, M. Asenjo, M. Bertran, 2004, European Journal of Epidemiology.

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

A. Borobia, A. Carcas, D. Lora, 2022, eClinicalMedicine.

How do we measure gender discrimination? Proposing a construct of gender discrimination through a systematic scoping review

M. Bertran, L. de la Torre-Pérez, Alba Oliver-Parra, 2022, International Journal for Equity in Health.

Cost analysis of two strategies for preventing hepatitis A virus infection in Spanish travellers to developing countries

J. Bayas, M. San-Martín, A. González, 2001, Epidemiology and Infection.

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital.

J. Roca, J. Garcia-Aymerich, M. Jansà, 2009, QJM : monthly journal of the Association of Physicians.

Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital.

G. Sanz, C. Castell, M. Jansà, 2010, Patient education and counseling.

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

A. Borobia, A. Carcas, J. Frías, 2021, The Lancet.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

A. Borobia, A. Carcas, D. Lora, 2021, SSRN Electronic Journal.

[Translation and cross-cultural adaptation of the Quick Environmental Exposure and Sensitivity Inventory for use in the Spanish population].

G. Mena, A. Trilla, V. Sequera, 2013, Medicina clinica.

Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic

I. Baeza, E. Vieta, M. Bernardo, 2020, Journal of Affective Disorders.

Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)

J. Bartra, Cristina Carrera, Sara Gómez, 2022, BioDrugs.

Phenotypic differences between male physicians, surgeons, and film stars: comparative study

M. Aymerich, A. Trilla, M. Bertran, 2006, BMJ : British Medical Journal.

[Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].

C. Codina, X. Carné, A. Trilla, 2000, Enfermedades infecciosas y microbiologia clinica.

[Cost analysis of cardiac transplantation in a Spanish hospital].

E. Roig, A. Trilla, M. Asenjo, 2006, Medicina clinica.